• SENSEX 73,709.69
    -143.21 (--0.19%)
  • BANKNIFTY 54,976.90
    -511.20 (--0.92%)
  • Max Healthcare
    811.50 811.50(%)
  • L&T Technology
    4,140.50 4,746.95(%)
  • Bajaj Finance
    919.00 788.40(%)
  • NSE
    1,705.00 1,705.00(%)
  • Reliance Industries
    1,234.60 1,611.20(%)
  • TCS
    2,533.10 3,336.70(%)
  • PC Jeweller
    19.14 19.14(%)
  • Cupid
    343.65 369.70(%)
  • HD Fire Protect
    338.00 338.00(%)
  • Infosys
    1,171.00 1,727.85(%)
  • ZF Commercial
    2,073.00 2,053.38(%)
  • Aditya Infotech
    3,879.70 1,301.10(%)
  • HDFC Bank
    698.35 682.00(%)
  • Fractal Analyt.
    828.00 1,119.60(%)
  • SS Retail
    724.90 888.00(%)
  • ICICI Bank
    1,409.50 1,479.90(%)
  • APL Apollo Tubes
    2,052.10 1,691.05(%)
  • Sun Pharma.Inds.
    1,721.70 1,583.60(%)
  • Netweb Technol.
    4,575.95 2,942.45(%)
  • CreditAcc. Gram.
    1,129.35 1,112.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kerala Ayurveda Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 4855.0
  • ISIN : INE817B01025
141.45 -5 (-3.48%)
  • As on 21 Oct 2026 (EOD)

  • Today’s Low

    141.00

  • Today’s High

    148.00

  • Open

    148.00

  • Perv Close

    146.55

  • 52W Low

    141.00

  • 52W High

    448.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    183.82

  • Div & Yield %

    0.00

  • Book Value(₹)

    28.05

  • Debt-Equity Ratio

    -3.48

  • AGM Date

    21-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    6.13

  • Mar.Cap (₹Cr.)

    183.82

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    13.00

  • BV (₹)

    28.10

  • Sales( ₹ in Cr.)

    85.48

  • NP (in Cr.)

    -14.74

  • NP Var(%)

    -7.0

  • Div%

    0.0

  • CPS (₹)

    -8.60

  • EPS (₹)

    -11.30

  • Traded Value (₹ in Lakhs)

    183.82

  • 52 Week High

    448.00

  • 52 Week Low

    141.00

  • Price BSE

    141.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    183.82

  • P/C Ratio

    -16.40

  • P/E Ratio

    -12.40

  • Price Vs.BV

    -11.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 77.95 73.14 63.30 55.80 43.20 53.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 77.95 73.14 63.30 55.80 43.20 53.68
Other Income 5.17 3.01 0.06 0.30 0.17 0.16
Stock Adjustments 0.29 3.32 -0.11 0.27 -1.65 0.36
Total Income 83.41 79.47 63.25 56.37 41.72 54.20
EXPENDITURE :            
Raw Materials 21.53 23.00 17.55 16.37 12.92 13.98
Power and Fuel Cost 1.71 2.12 2.08 2.01 1.09 1.72
Employee Cost 35.52 20.23 15.98 12.17 13.06 16.03
Other Manufacturing Expenses 2.77 3.86 4.06 3.26 3.13 4.52
Selling and Administration Expenses 26.76 21.98 18.21 14.02 11.13 14.50
Miscellaneous Expenses 2.55 1.47 -2.47 0.52 0.01 0.20
Employee Benefit Expenses 35.52 20.23 15.98 12.17 13.06 16.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 90.83 72.66 55.42 48.34 41.34 50.94
Operating Profit -7.41 6.81 7.82 8.03 0.38 3.26
Interest 3.92 5.40 4.81 6.03 6.14 1.37
Gross Profit -11.33 1.41 3.01 2.00 -5.76 1.89
Depreciation 2.15 1.57 0.64 0.77 0.82 0.68
Profit Before Tax -13.48 -0.16 2.37 1.23 -6.58 1.21
Current Tax 0.28 0.06 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 -0.28 -0.52 0.35 -1.63 0.34
Reported Net Profit -13.78 0.05 2.89 0.89 -4.95 0.88
Extraordinary Items 0.00 0.00 2.43 0.00 0.00 0.00
Adjusted Net Profit -13.78 0.05 0.46 0.89 -4.95 0.88
Adjustment below Net Profit -9.70 -9.96 0.37 0.34 0.32 0.30
P & L Balance brought forward -8.41 -8.11 -11.37 -12.60 -7.97 -9.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -31.89 -18.02 -8.11 -11.37 -12.60 -7.97
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -11.45 0.04 2.74 0.84 -4.69 0.83
Earnings Per Share(Adj)-Unit Curr -11.45 0.04 2.74 0.84 -4.69 0.83
Book Value 20.88 27.24 13.77 10.68 9.51 13.90
Book Value(Adj)-Unit Curr 20.88 27.24 13.77 10.68 9.51 13.90

Shareholding Pattern

  • Promoter Group

    35.61%

  • Public Share Holding

    64.39%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 3,996,627 30.75 3,996,627 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,996,627 30.75 3,996,627 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 630,399 4.85 630,399 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 630,399 4.85 630,399 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,709 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,976 0.02 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,685 0.04 0 2
2] Non Institution
Bodies Corporate 1,563,989 12.04 1,555,003 104
Clearing Members 0 0.00 0 0
Directors of their Relatives 472,879 3.64 472,879 5
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 225,402 1.73 83,840 176
Foreign Non Institution Other 25,737 0.20 0 1
Hindu Undivided Families 609,003 4.69 609,003 183
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,885,582 22.21 2,885,582 38
Individuals holding nominal share capital up to Rs. 1 lakh 2,546,959 19.60 2,406,634 10,034
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 250 0.00 130 4
Sub Total 8,363,374 64.36 8,046,644 10,554
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,995,085 100.00 12,673,670 10,559

Company Background

Kerala Ayurveda LtdPharmaceuticals - Indian - Formulations

  • Kerala Ayurveda Ltd
  • BSE Code : 4855.0
  • ISIN : INE817B01025

  • Incorporation Year

    1992

  • Registered Office

    VII/415 Nedumbassery
    Athani P O Aluva, Ernakulam,
    Kerala-683585

  • Telephone

    91-484-2476301/2/3/4

  • FAX

    91-484-2474376

  • Chairman

    Ramesh Vangal

  • Managing Director

  • Company Secretary

  • Auditor

    G Joseph & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Integrated Registry Mgt Servic
    Kences Tower ,
    2nd Floor No 1 ,Ramakrishna Street
    Mumbai - Chennai - 600 017

Kerala Ayurveda Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kerala Ayurveda 141.45 77.86 72.69 -7.51 0.00
Abbott India 25,744.40 7,217.19 6,929.05 33.88 43.78
Astrazeneca Phar 6,076.90 2,304.07 2,275.58 89.56 27.86
Glaxosmi. Pharma 2,463.75 3,932.76 3,790.20 39.36 58.17
Novartis India 1,768.90 393.10 354.33 44.67 15.94
Cipla 1,313.80 20,102.60 18,979.95 34.53 13.88
Bliss GVS Pharma 609.80 773.53 729.81 56.67 12.51
Amrutanjan Healt 495.10 520.13 502.55 26.52 24.16
Fermenta Biotec. 465.60 474.15 450.25 21.74 18.77
Guj. Themis Bio. 351.30 168.25 165.82 93.93 18.05
Ambalal Sarabhai 36.94 19.52 3.94 68.41 6.77